QA

Applications are invited for the following posts at Department of Pharmaceutical Sciences, Saurashtra University, Rajkot on self-finance contractual basis of 11 months tenure.

Post : Faculty Jobs

IQVIA™ is The Human Data Science Company™, focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward.

Post : Senior QA Auditor

We are the manufacturer and exporter of Pharmaceuticals from head office Delhi , Mfg Unit at Vadodara

Post: Qc / Mkt / Office Incharge

Macleods has its presence in over 30 countries with more than 300 registrations.The export range of Macleods are manufactured in a unit that has QSM approval from WHO-Geneva, and certifications from various International Regulatory Authorities like - USFDA, MCC, UKMHRA, MOH – Belarus, INVIMA – Colombia, National Drugs Authority - Uganda, Food and Drugs Board - Ghana, MCAZ – Zimbabwe, Pharmacy and Poisons Board Kenya, Pharmacy Board Tanzania etc.

Shree Dhanvantary Pharmacy College (SDPC), established in 2005 by Shree Sahkar Education Trust, Surat.  During this brief tenure of eleven years, it has made rapid strides of progress to become one of the premier institutes of Pharmacy in Gujarat. This institute is approved by AICTE, PCI & affiliated to GTU and currently offering B.Pharm, M.Pharm (Pharmaceutical Chemistry, Pharmaceutics, Pharmacology & Quality Assurance), Pharm.D. & Ph. D. courses.

Post : Professor

Mankind Pharma Is one of India's leading healthcare companies. Today, we have more than 14,000 employees and total turnover of INR 4500 Crore. Today, Mankind operates In 22 overseas countries across Asia, Africa, South East Asia and Gulf countries. The group has state-of-the-art manufacturing facility located at Paonta Sahib and Sikkim for manufacturing Solid Orals, Parenteral, Ophthalmic preparations and API manufacturing facility at Behror, Rajasthan. We have world class, state of the art R&D centre at Manesar, Delhi NCR. We are looking for young and dynamic personnel from Pharma background with proven track records, who have exposure to advance market operations (USFDA, TGA, EDQM, MHRA, etc) for Tablets, Capsules, Sterile Injectable, Potent products & Ophthalmic Products Formulation Unit at Paonta Sahib Location in Himachal Pradesh, for API unit at Sotanala-Behror (Rajasthan), for Development Quality Assurance at Manesar, Delhi NCR

Shree Dhanvantary Pharmaceutical Analysis and Research Centre (SDPARC) is a contract research organization established in 2006 and is managed by RIBOSOME PHARMA PVT. LTD., Surat. SDPARC offers a wide range of analytical & research services for small, medium and large scale pharmaceutical, ayurvedic, bulk drug, chemical, food and cosmetic industries. The centre is approved by the Food and Drug Control Administration (FDCA), Gujarat state as a public testing laboratory and is spread over 8,000 sq. ft. area. The centre is equipped with state of the art analytical facilities to cater to the needs of our clients and provides accurate, prompt and cost-effective analytical services in compliance with cGMP, GMP and various pharmacopeia guidelines.

Post : QA

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. We are looking suitable candidates for below openings at our flagship formulation facility located at Paithan Aurangabad, which is approved by the US FDA, UK MHRA. It also holds WHO pre- qualification.

Data Integrity (DI) has become a focal point of FDA inspections, as is evidenced by the number of warning letters citing data integrity and the resulting number of import alerts. Company Quality Management Systems are being scrutinized as to how the integrity of raw data (both electronic and manual) generated in the Quality Control Laboratory and in Operations (Manufacturing and Engineering) can be assured. The FDA is now including recommendations for recipients to obtain 3rd party assistance when addressing DI issues.  Indicators of potential Data Integrity issues are an unreasonably low number of deviations, OOS incidents and EM excursions.  Regulatory non-compliance is always a serious area of concern for the Indian pharmaceutical sector. With 13 warning letters being issued in FY 2015 and 9 warning letters in FY 2016, Data Integrity still continues to be a severe problem to be tackled.